CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-10 | Farrell Michael J. Chief Executive Officer | Gift | −1,000 | 4,090 | ||
| 2022-11-10 | Farrell Michael J. Chief Executive Officer | Gift | +1,000 | 4,880 | ||
| 2022-11-10 | Farrell Michael J. Chief Executive Officer | Sale | −4,880 | $220.83 | $1.1M | 0 |
| 2022-11-07 | Sandercock Brett Chief Financial Officer | Sale | −4,000 | $212.02 | $848K | 106,303 |
| 2022-11-03 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,545 | $215.23 | $333K | 102,334 |
| 2022-10-31 | FARRELL PETER C Director | Sale | −9,050 | $221.98 | $2.0M | 183,052 |
| 2022-10-31 | FARRELL PETER C Director | Gift | −4,550 | 178,502 | ||
| 2022-10-17 | Farrell Michael J. Chief Executive Officer | Option exercise | +5,675 | $57.76 | $328K | 428,245 |
| 2022-10-17 | Farrell Michael J. Chief Executive Officer | Sale | −5,675 | $214.58 | $1.2M | 422,570 |
| 2022-10-17 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −5,675 | 77,240 | ||
| 2022-10-14 | Douglas Robert Andrew President and COO | Option exercise | +1,145 | $58.24 | $67K | 29,553 |
| 2022-10-14 | Douglas Robert Andrew President and COO | Option exercise | +16,888 | $58.24 | $984K | 46,441 |
| 2022-10-14 | Douglas Robert Andrew President and COO | Sale | −11,355 | $215.09 | $2.4M | 35,086 |
| 2022-10-14 | Douglas Robert Andrew President and COO | Option exercise · ResMed Common Stock Options | −1,145 | 34,920 | ||
| 2022-10-14 | Douglas Robert Andrew President and COO | Option exercise · ResMed Common Stock Options | −16,888 | 18,032 | ||
| 2022-10-03 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,545 | $220.19 | $340K | 103,879 |
| 2022-09-15 | Farrell Michael J. Chief Executive Officer | Option exercise | +5,675 | $57.76 | $328K | 428,245 |
| 2022-09-15 | Farrell Michael J. Chief Executive Officer | Sale | −5,675 | $228.96 | $1.3M | 422,570 |
| 2022-09-15 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −5,675 | 82,915 | ||
| 2022-09-15 | Douglas Robert Andrew President and COO | Option exercise | +1,145 | $58.24 | $67K | 22,709 |
Page 25 of 28 · 548 trades